Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 2
1989 1
1990 4
1991 3
1992 2
1993 9
1994 12
1995 6
1996 6
1997 5
1998 9
1999 5
2000 6
2001 1
2002 5
2003 6
2004 13
2005 11
2006 7
2007 13
2008 17
2009 22
2010 15
2011 14
2012 17
2013 22
2014 22
2015 27
2016 25
2017 28
2018 27
2019 23
2020 23
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

384 results
Results by year
Filters applied: . Clear all
Page 1
Normal and pathologic concentrations of uremic toxins.
Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, Argiles A; European Uremic Toxin Work Group. Duranton F, et al. J Am Soc Nephrol. 2012 Jul;23(7):1258-70. doi: 10.1681/ASN.2011121175. Epub 2012 May 24. J Am Soc Nephrol. 2012. PMID: 22626821 Free PMC article. Review.
Proteome-based classification of Nonmuscle Invasive Bladder Cancer.
Stroggilos R, Mokou M, Latosinska A, Makridakis M, Lygirou V, Mavrogeorgis E, Drekolias D, Frantzi M, Mullen W, Fragkoulis C, Stasinopoulos K, Papadopoulos G, Stathouros G, Lazaris AC, Makrythanasis P, Ntoumas K, Mischak H, Zoidakis J, Vlahou A. Stroggilos R, et al. Among authors: mischak h. Int J Cancer. 2020 Jan 1;146(1):281-294. doi: 10.1002/ijc.32556. Epub 2019 Jul 26. Int J Cancer. 2020. PMID: 31286493 Free article.
Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure.
Ferreira JP, Verdonschot J, Collier T, Wang P, Pizard A, Bär C, Björkman J, Boccanelli A, Butler J, Clark A, Cleland JG, Delles C, Diez J, Girerd N, González A, Hazebroek M, Huby AC, Jukema W, Latini R, Leenders J, Levy D, Mebazaa A, Mischak H, Pinet F, Rossignol P, Sattar N, Sever P, Staessen JA, Thum T, Vodovar N, Zhang ZY, Heymans S, Zannad F. Ferreira JP, et al. Among authors: mischak h. Circ Heart Fail. 2019 May;12(5):e005897. doi: 10.1161/CIRCHEARTFAILURE.118.005897. Circ Heart Fail. 2019. PMID: 31104495 Free article.
Proteomics in Drug Development: The Dawn of a New Era?
Frantzi M, Latosinska A, Mischak H. Frantzi M, et al. Among authors: mischak h. Proteomics Clin Appl. 2019 Mar;13(2):e1800087. doi: 10.1002/prca.201800087. Epub 2019 Feb 25. Proteomics Clin Appl. 2019. PMID: 30724014 Review.
Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial.
Tofte N, Lindhardt M, Adamova K, Bakker SJL, Beige J, Beulens JWJ, Birkenfeld AL, Currie G, Delles C, Dimos I, Francová L, Frimodt-Møller M, Girman P, Göke R, Havrdova T, Heerspink HJL, Kooy A, Laverman GD, Mischak H, Navis G, Nijpels G, Noutsou M, Ortiz A, Parvanova A, Persson F, Petrie JR, Ruggenenti PL, Rutters F, Rychlík I, Siwy J, Spasovski G, Speeckaert M, Trillini M, Zürbig P, von der Leyen H, Rossing P; PRIORITY investigators. Tofte N, et al. Among authors: mischak h. Lancet Diabetes Endocrinol. 2020 Apr;8(4):301-312. doi: 10.1016/S2213-8587(20)30026-7. Epub 2020 Mar 2. Lancet Diabetes Endocrinol. 2020. PMID: 32135136 Clinical Trial.
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.
Good DM, Zürbig P, Argilés A, Bauer HW, Behrens G, Coon JJ, Dakna M, Decramer S, Delles C, Dominiczak AF, Ehrich JH, Eitner F, Fliser D, Frommberger M, Ganser A, Girolami MA, Golovko I, Gwinner W, Haubitz M, Herget-Rosenthal S, Jankowski J, Jahn H, Jerums G, Julian BA, Kellmann M, Kliem V, Kolch W, Krolewski AS, Luppi M, Massy Z, Melter M, Neusüss C, Novak J, Peter K, Rossing K, Rupprecht H, Schanstra JP, Schiffer E, Stolzenburg JU, Tarnow L, Theodorescu D, Thongboonkerd V, Vanholder R, Weissinger EM, Mischak H, Schmitt-Kopplin P. Good DM, et al. Among authors: mischak h. Mol Cell Proteomics. 2010 Nov;9(11):2424-37. doi: 10.1074/mcp.M110.001917. Epub 2010 Jul 8. Mol Cell Proteomics. 2010. PMID: 20616184 Free PMC article.
Drug repurposing in oncology.
Frantzi M, Latosinska A, Mokou M, Mischak H, Vlahou A. Frantzi M, et al. Among authors: mischak h. Lancet Oncol. 2020 Dec;21(12):e543. doi: 10.1016/S1470-2045(20)30610-0. Lancet Oncol. 2020. PMID: 33271100 No abstract available.
Tissue Proteomics in Vascular Disease.
Albalat A, Mullen W, Husi H, Mischak H. Albalat A, et al. Among authors: mischak h. Methods Mol Biol. 2017;1527:53-60. doi: 10.1007/978-1-4939-6625-7_4. Methods Mol Biol. 2017. PMID: 28116706 Review.
Proteomics and personalized medicine: a focus on kidney disease.
Siwy J, Mischak H, Zürbig P. Siwy J, et al. Among authors: mischak h. Expert Rev Proteomics. 2019 Sep;16(9):773-782. doi: 10.1080/14789450.2019.1659138. Epub 2019 Aug 23. Expert Rev Proteomics. 2019. PMID: 31441341 Review.
384 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page